IDH2 and breast carcinoma: Although IDH2 genes are rarely mutated in breast cancer [40], nearly 35% of cases either have IDH2 amplification or mRNA overexpression (Fig. 4, Additional file 1: Fig. S11), and it appears that IDH2 expression is correlated with worse prognosis in primary breast cancer (Fig. 4).